|
Resource utilization
Citations 11-14 of 14 total displayed.
|
Past content
(since Aug 2000):
|
- Clinical Investigations and Reports
Effect of Clinical Risk Stratification on Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: The Canadian Implantable Defibrillator Study
- Robert Sheldon, Bernie J. O’Brien, Gordon Blackhouse, Ron Goeree, Brent Mitchell, George Klein, Robin S. Roberts, Michael Gent, and Stuart J. Connolly
Circulation 2001;104:1622-1626, doi:10.1161/hc3901.096720
[Abstract]
[Full text]
- Clinical Investigations and Reports
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy
- David A. Morrow, Elliott M. Antman, Andrew Charlesworth, Richard Cairns, Sabina A. Murphy, James A. de Lemos, Robert P. Giugliano, Carolyn H. McCabe, and Eugene Braunwald
Circulation 2000;102:2031-2037
[Abstract]
[Full text]
- Correspondence
Simple Index for Prediction of Cardiac Risk in Stable Patients Undergoing Nonurgent Major Noncardiac Surgery: What About the More Severely Compromised Patients? • Response
- Luc A. Michel, Alain Rosiere, Thomas H. Lee, Edward R. Marcantonio, Carol M. Mangione, Eric J. Thomas, Carisi A. Polanczyk, E. Francis Cook, David J. Sugarbaker, Magruder C. Donaldson, Robert Poss, Kalon K.L. Ho, Lynn E. Ludwig, Alex Pedan, and Lee Goldman
Circulation 2000;102:e106
[Full text]
- Clinical Investigations and Reports
Cost-Effectiveness of Treating Hyperlipidemia in the Presence of Diabetes : Who Should Be Treated?
- Steven A. Grover, Louis Coupal, Hanna Zowall, and Marc Dorais
Circulation 2000;102:722-727
[Abstract]
[Full text]
|
|
